We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+7.41%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$2.06B
AUM Growth
+$150M
Cap. Flow
+$22.9M
Cap. Flow %
1.11%
Top 10 Hldgs %
40.15%
Holding
380
New
47
Increased
139
Reduced
153
Closed
18
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
376
Target
TGT
$62.1B
-22,405
Closed -$2.34M
TMUS icon
377
T-Mobile US
TMUS
$193B
-1,098
Closed -$293K
UNH icon
378
UnitedHealth
UNH
$382B
-695
Closed -$364K
VCR icon
379
Vanguard Consumer Discretionary ETF
VCR
$5.84B
-662
Closed -$215K
VO icon
380
Vanguard Mid-Cap ETF
VO
$106B
-4,064
Closed -$263K

Similar funds

Trilogy Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Trilogy Capital held 380 positions worth $2.06B, up 7.8% from $1.91B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trilogy Capital's Q2 2025 filing shows 47 new, 139 increased, 153 reduced and 18 closed positions. Its largest new stake was Vanguard Long-Term Bond ETF: 424,610 shares worth $29.5M. The largest sale was Invesco S&P 500 Quality ETF, an estimated $55.6M.

By sector, the portfolio is most concentrated in Financials at 4.1% of assets, up from 1.4% a quarter earlier, followed by Technology and Healthcare.

  • Trilogy Capital's largest Q2 2025 buy was Vanguard Long-Term Bond ETF: 424,610 shares worth $29.5M.
  • Trilogy Capital added most to State Street Technology Select Sector SPDR ETF in Q2 2025, an estimated $63.6M increase.
  • Trilogy Capital's biggest Q2 2025 reduction was Invesco S&P 500 Quality ETF, cutting an estimated $55.6M.
  • Trilogy Capital fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2025, selling an estimated $10.3M.
  • Trilogy Capital's ten largest holdings make up 40% of its $2.06B portfolio in Q2 2025.
  • Trilogy Capital opened 47 new positions and closed 18 in Q2 2025.
  • Trilogy Capital's portfolio value rose 7.8% quarter-over-quarter to $2.06B.

Based on Trilogy Capital's 13F filing for Q2 2025, filed 18 Jul 2025.